More articles about: Weight Management Non-Surgical
Health Lab
Randy Seeley gets a lot of questions about GLP-1s. Here’s why
A Michigan Medicine Ph.D. researcher dissected bariatric surgery to understand how it actually works, contributing to obesity therapies that have given rise to drugs like Ozempic and Wegovy.
Health Lab
Healthy good tidings: 20 ways to manage your diet this season
Staying healthy during the holidays can be a tall order, but arranging your plate and your plans with these tips can help.
Health Lab
How do GLP-1 weight loss drugs affect the liver?
Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.
Health Lab
Navigating a weight loss journey
Losing weight can feel like a constant uphill battle for many people. However, patients like Marsha Burks found success with The Weight Navigation Program at Michigan Medicine, a program aiming to make weight loss easier with structured, individualized support.
Health Lab
Adding obesity experts to primary care clinics improves patients’ weight loss outcomes
A weight navigation program for primary care patients with obesity led to more use of proven weight management strategies and more weight loss
Health Lab
Should heart patients consider taking weight loss medications?
Cardiologist shares how weight loss medications may impact cardiovascular health.
Health Lab
Medicare doesn’t cover obesity drugs, but 76% of older adults think it should
Drugs approved for people with obesity or diabetes, such as Ozempic and Wegovy, can reduce risk for older adults; a new poll shows attitudes toward them
Health Lab
Bariatric endoscopy for weight loss: What is it and how does it work?
A gastroenterologist discusses several non-invasive therapies for treating obesity
